NOVA Participating in Multisite Clinical Trial

TMB-DrStaceyCoulter
Dr. Rachel A. “Stacey” Coulter

Dr. Rachel A. “Stacey” Coulter

Nova Southeastern University College of Optometry (NOVA) has been awarded up to $556,532 from the National Eye Institute of the National Institutes of Health for the work it will do along with other research centers as part of the national Convergence Insufficiency Treatment Trial – Attention and Reading Trial. Dr. Rachel A. “Stacey” Coulter is the NOVA principal investigator.

“Children who have convergence insufficiency sometimes suffer from poor reading performance and attention problems,” Dr. Coulter explained in a press release. “As the first large-scale randomized clinical trial to study this problem, outcomes of this study could lead to new therapies for some children with attention deficit hyperactivity disorder and reading problems. We are very excited that the National Eye Institute has funded our grant application, and we look forward to enrolling children into the study this fall.” The NOVA faculty research team consists of Dr. Coulter, Dr. Annette Bade, Dr. Pamela Oliver, Dr. Gregory Fecho, Dr. Erin Jenewein, Dr. Deborah Amster, Dr. Yin C. Tea, Dr. Jacqueline Rodena and Dr. Nicole Patterson.